MELAS SyndromeSymptoms, Doctors, Treatments, Advances & More
MELAS Syndrome Overview
Learn About MELAS Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Ayman El-Hattab is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Columbia, Missouri. Dr. El-Hattab is rated as an Elite provider by MediFind in the treatment of MELAS Syndrome. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses MELAS Syndrome, Neu Laxova Syndrome, Primary Carnitine Deficiency, and Microcephaly.
Baylor College Of Medicine
Fernando Scaglia is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Houston, Texas. Dr. Scaglia is rated as an Elite provider by MediFind in the treatment of MELAS Syndrome. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses MELAS Syndrome, Hypotonia, Primary Carnitine Deficiency, and Leigh Syndrome. Dr. Scaglia is currently accepting new patients.
Lisa Emrick is a Pediatrics specialist and a Pediatric Neurologist practicing medicine in Houston, Texas. Dr. Emrick is rated as an Elite provider by MediFind in the treatment of MELAS Syndrome. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses MELAS Syndrome, Hypotonia, CACH Syndrome, Cortical Dysplasia, and Gastrostomy. Dr. Emrick is currently accepting new patients.
Summary: The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.
Summary: This is a parallel arm non-randomized dose-escalation, open-label basket exploratory phase 1 clinical trial where Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes (MELAS) and Leber's hereditary optic neuropathy-Plus (LHON-Plus) participants will undergo simultaneous enrollment in two disease-based arms and receive daily oral doses of glycerol tributyrate to assess its safety and...